Aaron Biggs, CCC-SLP - Speech-Language Pathologist in Tahlequah, OK

Aaron Biggs, CCC-SLP is a Speech-language Pathologist based in Tahlequah, Oklahoma. Aaron Biggs is licensed to practice in Oklahoma (license number 14075820) and his current practice location is 303 W 4th St, Tahlequah, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (918) 728-0475.

NPI number for Aaron Biggs is 1124498142 and his current mailing address is 303 W 4th St, Tahlequah, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1124498142.

Contact Information

Aaron Biggs, CCC-SLP
303 W 4th St,
Tahlequah, OK 74464-5203
(918) 728-0475
Not Available



Healthcare Provider's Profile

Full NameAaron Biggs
GenderMale
SpecialitySpeech-language Pathologist
Location303 W 4th St, Tahlequah, Oklahoma
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1124498142
  • Provider Enumeration Date: 10/02/2015
  • Last Update Date: 10/02/2015

Medical Identifiers

Medical identifiers for Aaron Biggs such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1124498142NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 14075820 (Oklahoma)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Aaron Biggs is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Aaron Biggs, CCC-SLP
303 W 4th St,
Tahlequah, OK 74464-5203

Ph: (918) 728-0475
Aaron Biggs, CCC-SLP
303 W 4th St,
Tahlequah, OK 74464-5203

Ph: (918) 728-0475

News Archive

Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced favorable response and safety indications from a group of patients with advanced solid tumors (principally soft tissue sarcomas) in the Company's ongoing Phase 1b/2 clinical trial with INNO-206, its tumor-targeting conjugate of the commonly used chemotherapeutic agent doxorubicin.

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals, Inc. today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013.

NeuroVive signs agreement with Isomerase Therapeutics to develop and commercialize cyclophilin-inhibiting molecules

NeuroVive Pharmaceutical AB (publ) (STO:NVP), a leading mitochondrial medicine company, has signed a collaboration agreement with Isomerase Therapeutics to develop the molecules that were recently acquired from Biotica.

Renowned cardiologist wins TCT 2011 Geoffrey O. Hartzler Master Clinical Operator Award

Horst Sievert, MD, PhD, a renowned interventional cardiologist, was presented the TCT 2011 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

Ureteroscopic laser lithotripsy for upper urinary tract calculi with active fragment extraction

In this study, the authors have changed the paradigm for ureteroscopic stone removal in several ways:

Read more News

› Verified 5 days ago


Speech-Language Pathologist in Tahlequah, OK

Mrs. Emily Freise, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 400 E Ross St, Tahlequah, OK 74464
Phone: 918-458-4120    Fax: 918-458-4122
Jessica Keys, M.S., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1400 E Downing St, Tahlequah, OK 74464
Phone: 918-458-1883    Fax: 918-458-6331
Ms. Jessica Renee Roady, M.S., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1400 E Downing St, Tahlequah, OK 74464
Phone: 918-457-8036    
Mrs. Caley Rose Janzen, M.S., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1607 S Muskogee Ave Ste B, Tahlequah, OK 74464
Phone: 918-458-1883    Fax: 918-458-6331
Sandra Kay Becker, SPEECH-LANGUAGE PATH
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 117 Carol St, Tahlequah, OK 74464
Phone: 918-456-0850    
Ms. Mary Blenkarn Purdy, M.A.,CCC
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 310 W Keetoowah St, Tahlequah, OK 74464
Phone: 918-458-0639    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.